BRIEF published on 07/07/2025 at 15:05, 5 months 9 days ago Applied DNA Sciences se conforme aux normes de cotation du Nasdaq Biotechnologie Sciences Appliquées De L'ADN Conformité Au Nasdaq Technologies De L'ADN LineaRx
BRIEF published on 07/07/2025 at 15:05, 5 months 9 days ago Applied DNA Sciences Complies with Nasdaq Listing Standards Biotechnology Nasdaq Compliance Applied DNA Sciences DNA Technologies LineaRx
PRESS RELEASE published on 07/07/2025 at 15:00, 5 months 9 days ago Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements Applied DNA Sciences regains compliance with Nasdaq listing rule requiring minimum bid price of $1.00 per share. Company's securities to remain listed on Nasdaq Capital Market Nasdaq Compliance Applied DNA Sciences Nasdaq Capital Market Minimum Bid Price PCR-based DNA Technologies
BRIEF published on 06/17/2025 at 22:15, 5 months 29 days ago Transition de direction chez Applied DNA : le Dr Hayward, PDG, prend sa retraite Biotechnologie Changement De Direction Valeur Actionnariale ADN Appliqué Judy Murrah
BRIEF published on 06/17/2025 at 22:15, 5 months 29 days ago Leadership Transition at Applied DNA as CEO Dr. Hayward Retires Biotechnology Shareholder Value Leadership Change Applied DNA Judy Murrah
PRESS RELEASE published on 06/17/2025 at 22:10, 5 months 29 days ago Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward Judy Murrah appointed Chairperson and CEO of Applied DNA Sciences, succeeding Dr. James A. Hayward. Experienced executive aims to lead company's innovative DNA technologies CEO Appointment Applied DNA Sciences DNA Technologies Judy Murrah Dr. James A. Hayward
BRIEF published on 05/15/2025 at 22:10, 7 months 1 day ago Applied DNA Sciences enregistre une croissance modeste de ses revenus au deuxième trimestre 2025 Croissance Des Revenus Restructuration Stratégique Résultats Financiers Du Deuxième Trimestre Tendances Biopharmaceutiques Technologie De L'ADN
BRIEF published on 05/15/2025 at 22:10, 7 months 1 day ago Applied DNA Sciences Sees Modest Revenue Growth in Q2 2025 Revenue Growth Strategic Restructuring Q2 Financial Results DNA Technology Biopharma Trends
PRESS RELEASE published on 05/15/2025 at 22:05, 7 months 1 day ago Applied DNA Reports Second Quarter Fiscal 2025 Financial Results Applied DNA Sciences, Inc. (NASDAQ:APDN) reports a 44% Y/Y increase in LineaRx segment revenues contributing to a 6% total revenue growth. Strategic priorities and financial highlights for Q2 2025 disclosed Financial Results Strategic Priorities Applied DNA Sciences LineaRx Segment Therapeutic DNA Production
BRIEF published on 05/14/2025 at 17:35, 7 months 2 days ago Applied DNA Sciences publiera ses résultats financiers du deuxième trimestre et organisera une mise à jour pour les investisseurs Sciences Appliquées De L'ADN Conférence Téléphonique Pour Les Investisseurs Priorités Stratégiques Rediffusion Du Webcast Résultats Financiers Du Deuxième Trimestre 2025
Published on 12/16/2025 at 23:20, 2 hours 46 minutes ago Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III
Published on 12/16/2025 at 23:20, 2 hours 46 minutes ago GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/16/2025 at 23:07, 2 hours 59 minutes ago Linear Minerals Corp Closes First Tranche of Private Placement Financing
Published on 12/16/2025 at 22:20, 3 hours 46 minutes ago NuRAN Announces Intention to Close the Restructuring Transaction and Additional Debt Settlements
Published on 12/16/2025 at 19:25, 6 hours 41 minutes ago Cypher Metaverse Inc. Announces Signing of Definitive Agreement for Acquisition
Published on 12/17/2025 at 01:35, 31 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appointment of non-executive director
Published on 12/17/2025 at 00:10, 1 hour 56 minutes ago Samsung Expands Premium Micro RGB Lineup for 2026 with New Sizes and Advanced Features
Published on 12/16/2025 at 22:40, 3 hours 26 minutes ago Ovivo Completes the Sale of its Electronics Division to Ecolab and Starts a New Phase of Growth
Published on 12/16/2025 at 21:40, 4 hours 26 minutes ago Qatar's Years of Culture Initiative Announces Partner Countries for 2026 and 2027
Published on 12/16/2025 at 19:00, 7 hours 6 minutes ago UV GERMI: COMMUNIQUE RELATIF AU DEPOT D’UN PROJET D’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI PORTANT SUR 800 000 DE SES PROPRES ACTIONS EN VUE DE LA REDUCTION DE SON CAPITAL
Published on 12/16/2025 at 21:45, 4 hours 21 minutes ago Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 5 hours 56 minutes ago donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 5 hours 56 minutes ago Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 7 hours 13 minutes ago Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 7 hours 13 minutes ago Nombre total d'actions et droits de vote - novembre 2025
